2023 Legislative Session
The pace of the legislative session has picked up; new bills are being dropped (introduced) daily alongside significant movement on already introduced legislation. With only two weeks until Crossover Day (the last chance for a bill to be voted out of one Chamber and sent to the other), we expect to see the pace continue to pick up. Currently, legislation has been introduced that deals with certificate of need, biomarker testing, scope of practice, surprise billing, violence against healthcare workers, and more. The State Affairs team will continue representing Emory’s perspective at the Capitol and track any movement on bills under consideration. If you have any questions or concerns on a specific piece of legislation, please contact Sydney Wilkins at Sydney.Wilkins@emory.edu.
Committee Testimony Provided
Emory has been working alongside the American Cancer Society on HB 85, House Public Health Chairman Sharon Cooper’s biomarker testing bill that would require health benefit policy coverage for biomarker testing if supported by medical and scientific evidence. Dr. Suresh Ramalingam, Executive Director for the Winship Cancer Institute, provided expert testimony on this bill during the House Insurance Life and Health Subcommittee meeting. The State Affairs team is grateful for Dr. Ramalingam’s willingness to provide his expertise on biomarker testing to the subcommittee. The bill passed the full House, with a vote of 172-2, and is now on its way to the Senate. HB 85 has also gained traction in the media with numerous articles being written about its positive impact. Many of these articles, including one by the American Cancer Society, credits the Winship Cancer Institute of Emory for their support. |